Previous issues
-
Previous issues
Volume 29(Suppl) Feb 2023
Print ISSN: 2287-2728
Online ISSN: 2287-285X
- Congratulatory remarks
- Si Hyun Bae
- Clin Mol Hepatol. 2023;29(Suppl):S1-S1.
- Preface
- Yoon Jun Kim
- Clin Mol Hepatol. 2023;29(Suppl):S2-S2.
- Preface
- Seung Up Kim
- Clin Mol Hepatol. 2023;29(Suppl):S3-S3.
- Special thanks
- Seung Up Kim
- Clin Mol Hepatol. 2023;29(Suppl):S4-S4.
- Reviews Non-alcoholic fatty liver disease: Definition and subtypes
- Seul Ki Han, Soon Koo Baik, Moon Young Kim
- Clin Mol Hepatol. 2023;29(suppl):S5-S16.
- MAFLD: How is it different from NAFLD?
- Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
- Clin Mol Hepatol. 2023;29(Suppl):S17-S31.
- Global incidence and prevalence of nonalcoholic fatty liver disease
- Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
- Clin Mol Hepatol. 2023;29(Suppl):S32-S42.
- Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
- Peter Konyn, Aijaz Ahmed, Donghee Kim
- Clin Mol Hepatol. 2023;29(Suppl):S43-S57.
- Comparison between obese and non-obese nonalcoholic fatty liver disease
- Wah-Kheong Chan
- Clin Mol Hepatol. 2023;29(Suppl):S58-S67.
- Interaction between sarcopenia and nonalcoholic fatty liver disease
- Sae Kyung Joo, Won Kim
- Clin Mol Hepatol. 2023;29(Suppl):S68-S78.
- Risk factors in nonalcoholic fatty liver disease
- Eunji Ko, Eileen L. Yoon, Dae Won Jun
- Clin Mol Hepatol. 2023;29(Suppl):S79-S85.
- Nonalcoholic fatty liver disease and non-liver comorbidities
- Richie Manikat, Mindie H. Nguyen
- Clin Mol Hepatol. 2023;29(Suppl):s86-s102.
- Screening strategy for non-alcoholic fatty liver disease
- Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
- Clin Mol Hepatol. 2023;29(Suppl):S103-S122.
- Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
- Asako Nogami, Masato Yoneda, Michihiro Iwaki, Takashi Kobayashi, Yasushi Honda, Yuji Ogawa, Kento Imajo, Satoru Saito, Atsushi Nakajima
- Clin Mol Hepatol. 2023;29(Suppl):S123-S135.
- Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
- Jung Hwan Yu, Han Ah Lee, Seung Up Kim
- Clin Mol Hepatol. 2023;29(Suppl):S136-S149.
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- Sang Bong Ahn
- Clin Mol Hepatol. 2023;29(Suppl):S150-S156.
- Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
- Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne
- Clin Mol Hepatol. 2023;29(Suppl):S157-S170.
- Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
- Terry Cheuk-Fung Yip, Fei Lyu, Huapeng Lin, Guanlin Li, Pong-Chi Yuen, Vincent Wai-Sun Wong, Grace Lai-Hung Wong
- Clin Mol Hepatol. 2023;29(Suppl):S171-S183.
- Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
- Silvia Sookoian, Carlos J. Pirola
- Clin Mol Hepatol. 2023;29(Suppl):S184-S195.
- Identification of high-risk subjects in nonalcoholic fatty liver disease
- Christiane Stern, Laurent Castera
- Clin Mol Hepatol. 2023;29(Suppl):S196-S206.
- Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
- Karim Seif El Dahan, Darine Daher, Amit G. Singal
- Clin Mol Hepatol. 2023;29(Suppl):S207-S219.
- Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma
- Yuri Cho, Bo Hyun Kim, Joong-Won Park
- Clin Mol Hepatol. 2023;29(Suppl):S220-S227.
- Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
- Yi-wen Shi, Jian-Gao Fan
- Clin Mol Hepatol. 2023;29(Suppl):S228-S243.
- Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
- Georg Semmler, Christian Datz, Michael Trauner
- Clin Mol Hepatol. 2023;29(Suppl):S244-S260.
- The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
- Hyunwoo Oh, Won Sohn, Yong Kyun Cho
- Clin Mol Hepatol. 2023;29(Suppl):S261-S267.
- Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials
- Jihyun An, Joo Hyun Sohn
- Clin Mol Hepatol. 2023;29(Suppl):S268-S275.
- Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management
- Anja Geerts, Sander Lefere
- Clin Mol Hepatol. 2023;29(Suppl):S276-S285.
- Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
- Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra
- Clin Mol Hepatol. 2023;29(Suppl):S286-S301.
- Non-alcoholic fatty liver disease: the pathologist’s perspective
- Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim
- Clin Mol Hepatol. 2023;29(Suppl):S302-S318.
- Original Article The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
- George Chen, Bubu Banini, Albert Do, Joseph K. Lim
- Clin Mol Hepatol. 2023;29(Suppl):S319-S332.